31601 Tirzepatide for Sale
Compare supplier listings for Tirzepatide (CAS 2023788-19-2) — check price, grade and packaging, then open a product page or send an inquiry. View Suppliers
Top Quality Peptides Lyophilized Powder Tirzepatide Fitness and Weight Loss 99% high purity CAS 2023788-19-2
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
5mg,10mg,20mg,30mg,40mg,50mg,60mg/vial,10vials/box
GLP-1,Retatrutide,Tirzepatide,Peptides
99% pure peptide raw material flour factory directly supplies at the lowest price with the best quality raw materials CAS:2023788-19-2
-
Price:
$1/G FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
vial/box/bag/hermetic bag
GLP-1,Retatrutide,Tirzepatide,Peptides
Tirzepatide Raw Material Pharmaceutical Grade White powder 99%High Quality
-
Price:
Price on request
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
1g,2g,3g,4g,5g,10g/bottle
GLP-1,Retatrutide,Tirzepatide,Peptides
High Purity Tirzepatide CAS 2023788-19-2 Third-Party HPLC MS Lab Tested Lyophilized Peptide Powder
-
Price:
$44/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
Ten bottles per box
In Stock Tirzepatide Powder Fast Shipping From USA EU Warehouse No Customs Issues 10mg 5mg
-
Price:
$44/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
Ten bottles per box
Products You May Be Interested in
Direct Manufacturer / Factory-Direct Source Tirzepatide 99% White powder High Quality tirzepatide weight loss
-
Price:
$10.8/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10vials/box
CAS 2023788-19-2 TR10 TR15 TR20 TR30 TR40 TR50 TR60 weight loss Tirzepatide peptide Lyophilized Powder
-
Price:
$54/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
10Vials/box
Tirzepatide Lyophilized Peptide Powder 5mg 10mg 15mg Vials High Quality
-
Price:
$40/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
20 mg per vial; each box contains 10 vials.
tirzepatide High Quality, Low Price: Weight Loss Fat Reduction 2023788-19-2 99%
-
Price:
$30/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
30 mg per vial; each box contains 10 vials.
Tirzepatide Custom Lyophilized Peptide Tirzepatide 5mg 10mg 15mg Vials 2023788-19-2
-
Price:
$50/UNIT FOB
-
CAS No.:
2023788-19-2
-
Grade:
Pharmaceutical Grade
-
Content:
99%
-
Packaging:
20 mg per vial; each box contains 10 vials.
- Buying Tirzepatide on www.echemi.com where you will find large variety of good choices. Suppliers of 31601 Tirzepatide registered will be verified by the accurate information. Safe transaction of chemical will be made based on true information. We help you get chemicals in need continuously and meet registered Tirzepatide suppliers.
- The quality of Tirzepatide 2023788-19-2 will be secured by ECHEMI. The pursuit of high quality requires all partners of ECHEMI to be screened, whether its certificate, qualification or scale. Tirzepatide will reach global regulation and requirement of various regions. Further services on the whole supply chain can be provided with ECHEMI.
- We offer reasonable and fair market price of Tirzepatide to provide better products and services. Services of Tirzepatide like trade data and market price and insight can be subscribed on ECHEMI. You can enjoy the chemical supply chain services on ECHEMI. We will help you purchase Tirzepatide and run fast your business.
- •China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
- •Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
- •Novo Nordisk’s Semaglutide Faces Strong Competition: Eli Lilly’s Tirzepatide Officially Launched in China
- •Eli Lilly Revenue Reaches $31.5 Billion, Up 27%! Tirzepatide and Semaglutide Exceed $20 Billion
- •Novo Nordisk's 2024 Earnings Surge by 23%! Diabetes Drug Sales Skyrocket, but Facing Competition Pressure from Tirzepatide